Pee test breakthrough: no more 24-Hour jugs for myeloma patients?

NCT ID NCT05208086

Ongoing Diagnosis Sponsor: Intergroupe Francophone du Myelome Source: ClinicalTrials.gov ↗

First seen Apr 19, 2026 · Last updated May 09, 2026 · Updated 3 times

Summary

This study looks at whether a single urine sample can accurately detect myeloma proteins compared to the standard 24-hour urine collection. Researchers will enroll 180 multiple myeloma patients starting a new treatment. If successful, this could make monitoring much easier for patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

CH Bretagne Atlantique Vannes et Auray-P.Chubert

Vannes, France
CH de Dunkerque

Dunkirk, France
CH de Lens

Lens, France
CH de Versailles

Versailles, France
CHD Vendée

La Roche-sur-Yon, France
CHRU Bretonneau

Tours, France
CHRU Nantes

Nantes, France
CHU François Mitterand

Dijon, France
CHU Toulouse

Toulouse, France
CHU de Montpellier

Montpellier, France
Centre Hospitalier Lyon sud

Lyon, France
Centre Hospitalier Métropole de Savoie

Chambéry, France
Ch Annecy Genevois

Annecy, France
Ch Le Mans

Le Mans, France
Chu Pontchaillou

Rennes, France
Hopital Bicètre

Le Kremlin Bicètre, France
Hopital Claude Huriez-CHRU LILLE

Lille, France
Hôpital E. MULLER

Mulhouse, France

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA